Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group-Reference-Cited by-同舟云学术

Clinical group and modified TNM stage for rhabdomyosarcoma: A review from the Children's Oncology Group

Published:2022-03-06 Issue:6 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Crane Jacquelyn N.¹^ORCID,Xue Wei²,Qumseya Amira²,Gao Zhengya²,Arndt Carola A. S.³,Donaldson Sarah S.⁴^ORCID,Harrison Douglas J.⁵,Hawkins Douglas S.⁶^ORCID,Linardic Corinne M.⁷,Mascarenhas Leo⁸^ORCID,Meyer William H.⁹,Rodeberg David A.¹⁰^ORCID,Rudzinski Erin R.¹¹^ORCID,Shulkin Barry L.¹²^ORCID,Walterhouse David O.¹³,Venkatramani Rajkumar¹⁴,Weiss Aaron R.¹⁵

Affiliation:

1. Department of Pediatrics Stanford University Stanford California USA

2. Department of Biostatistics, College of Public Health and Health Professions and College of Medicine University of Florida Gainesville Florida USA

3. Department of Pediatric and Adolescent Medicine Mayo Clinic and Foundation Rochester Minnesota USA

4. Department of Radiation Oncology Stanford University Stanford California USA

5. Department of Pediatrics, Texas Children's Cancer Center Baylor College of Medicine Houston Texas USA

6. Department of Pediatrics Seattle Children's Hospital University of Washington School of Medicine Seattle Washington USA

7. Department of Pediatrics Duke University School of Medicine Durham North Carolina USA

8. Children's Hospital Los Angeles and University of Southern California Keck School of Medicine Los Angeles California USA

9. University of Oklahoma Health Sciences Center Oklahoma City Oklahoma USA

10. Division of Pediatric Surgery, Department of Surgery East Carolina University Greenville North Carolina USA

11. Department of Laboratories Seattle Children's Hospital Seattle Washington USA

12. Department of Diagnostic Imaging St. Jude Children's Research Hospital Memphis Tennessee USA

13. Department of Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago Northwestern University Feinberg School of Medicine Chicago Illinois USA

14. Department of Pediatrics Baylor College of Medicine Houston Texas USA

15. Department of Pediatrics Maine Medical Center Portland Maine USA

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29644

Reference77 articles.

1. Pretreatment TNM staging of childhood rhabdomyosarcoma: a report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group;Lawrence W;Pediatric Oncology Group. Cancer,1997

2. The intergroup rhabdomyosarcoma study-I.A final report

3. The intergroup rhabdomyosarcoma study.A preliminary report

4. Rhabdomyosarcoma: Review of the Children's Oncology Group (COG) soft-tissue Sarcoma committee experience and rationale for current COG studies

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addition of temsirolimus to chemotherapy in children, adolescents, and young adults with intermediate-risk rhabdomyosarcoma (ARST1431): a randomised, open-label, phase 3 trial from the Children's Oncology Group;The Lancet Oncology;2024-07

2. PET/CT and PET/MR in Soft Tissue Sarcoma: An Update;Seminars in Nuclear Medicine;2024-05

3. Risk factors for neurocognitive impairment, emotional distress, and poor quality of life in survivors of pediatric rhabdomyosarcoma: A report from the Childhood Cancer Survivor Study;Cancer;2024-02-19

4. Maximizing the Accuracy of Time Series Analysis for the Early Detection of Rhabdomyosarcomas;2024 International Conference on Optimization Computing and Wireless Communication (ICOCWC);2024-01-29

5. Adolescents and young adults with rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group;Pediatric Blood & Cancer;2024-01-28